Marı́a Dolores Caballero

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma

Philippe Armand, Scott J. Rodig, Catherine Thiéblemont et al. · Journal of Clinical Oncology · 2019 · 259 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 Patients From the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative Group

Anna Sureda, R. Arranz, A Iriondo et al. · Journal of Clinical Oncology · 2001 · 231 citations

Medicine, Clinical Sciences, Oncology +15

Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse

Anna Sureda, M. Constans, A Iriondo et al. · Annals of Oncology · 2005 · 220 citations · Full text

Medicine, Hematology, Oncology +17

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes

Rodrigo Martino, Marı́a Dolores Caballero, José Antonio Pérez‐Simón et al. · Blood · 2002 · 179 citations · Full text

Medicine, Hematology, Immunology +16

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study

E. Condé, Montserrat Arnán, Miguel Canales et al. · Haematologica · 2008 · 170 citations · Full text

Medicine, Immunology, Oncology +14